Lupus Flashcards
Definition & Pathogenesis
Autoimmune disease due to susceptible genes + environmantal factors
cells undergo apoptosis and cell DNA, histones and other proteins become targets for autoantibodies like antinuclear ab + less clearance of these apoptotic molecules
they form complexes and travel throughout the body causing local inflammatory reaction, they also activate complement systems (Type III reaction)
Can present with fecer and arthritis, malaise, weight loss & rash
Triggers
Genes, Uv radiation, medications, estrogen
Criteria (DOPMAINE RASH)
need 4 or more:
- skin: 1) malar rash 2) discoid rash 3) photosensitivity
- Mucosa: 4) ulcers: mouth/nose 5) serositis (pleuritis, pericarditis, libman sacks endocarditis, …)
- joints: 6) arthritis (2 or >)
- kidney: 7) renal disorders (proteinuria, DPGN, ..)
- Brain: 8) neurologic sympotms :seizure psychosis
- hematologic: 9) anemia, thrombocytopenia, leukopenia
- Antibodies: ANcA, Anti-smith, Anti-dsDNA, Anti-phopholipid (cardiolipin, lupus ab, anti B2GP1)
Acute cutaneous lupus erythematosus
Most commonly associated with SLE predict the recurrence of systemic disease or prognosis of the disease ANCA systemic + 7% butterfly malar rash sun exposure
Subacute cutaneous lupus
related to medications (CCB, Phenytoin, INH, NSAIDS, ACEI, tetracyclines and sun exposure (Photo aggravated dermatoses)
doesn’t scar
50% chance of having SLE but not severe
epidermis and upper dermis
anti-Ro/SSA autoantibodies (ab against cytoplasmic proteins )
Discoid
scars & need early treatment
epidermis, upper and lower dermis, and adnexal structures (chronic)
limited to skin with IgG, IgM deposited at the dermal-epidermal junction and no ab
paresthesia
may be found on the ears, face, trunk, and extremities
Type of rash in subacute LE
Erythematous papules and scaly, hyperkeratotic, annular/ polycyclic plaques, bright red annular
appears suddenly
mainly affects the upper trunk and dorsi of the hands
Type of rash in discoid LE (early & late)
early lesions are sharply demarcated erythematous scale papules and plaque, follicular plugging, and early scarring
Late lesions: atrophic plaques with central scarring, telangiectasis, and hypopigmentation
CDLE on the scalp: oval, scarring area of alopecia due to fibrosis. Active erythematous margin and a white atrophic inactive center
Diagnosis
Antinuclear antibodies, Anti DNA antibodies
CBC + urinalysis
Skin histology: epidermal atrophy, hyper/paraceratosis, edema, vaculisation, inflammatory infiltrate
direct immunofluorescence (DIF): IgG deposits on basal layer
Local Treatment
- Sun protection
- Topical and intralesional corticosteroids
- Topical calcineurin inhibitors
- Topical retinoids
Systemic treatment
• Low dose corticosteroids
• NSAIDs
• Azathiopine
• Hydroxychloroquine (po qd–bid)- antimalarial
• Chloroquine (po qd)- antimalarial drug
• Quinacrine (po qd)-combination of the 2
If there is obvious renal and CNS involvement or significant systemic upset, then high-dose pulsed
methylprednisolone may be required